4 Ways To Level The Field Between Retail And Institutional Biotech Investors

Published: Nov 04, 2016

Occasionally I like to highlight early-stage and independent work in life sciences, apart from the low-market-cap public companies in which I invest for the Life Sciences Fund. Last week I discussed several good ideas being developed in reproductive medicine and women’s health. Today I’ll look at biotechnology research.

Not all biotech entrepreneurship starts in the laboratory.

Back to news